A new study announced by Istituto Superiore di Sanità (ISS, Rome, Italy) and published in "Frontiers in Immunology, February 13, 2019" suggests new avenues toward cure of HIV: the administration of the recombinant HIV-1 Tat protein (rTAT) to people...
